BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9724039)

  • 1. Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2.
    Fuster D; Escher G; Vogt B; Ackermann D; Dick B; Frey BM; Frey FJ
    Endocrinology; 1998 Sep; 139(9):3849-54. PubMed ID: 9724039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced 11beta-hydroxysteroid dehydrogenase activity in the remaining kidney following nephrectomy.
    Escher G; Vogt B; Beck T; Guntern D; Frey BM; Frey FJ
    Endocrinology; 1998 Apr; 139(4):1533-9. PubMed ID: 9528931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furosemide inhibits 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo.
    Escher G; Meyer KV; Vishwanath BS; Frey BM; Frey FJ
    Endocrinology; 1995 Apr; 136(4):1759-65. PubMed ID: 7895688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
    Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
    Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 11beta-hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol.
    Guo J; Reidenberg MM
    J Lab Clin Med; 1998 Jul; 132(1):32-8. PubMed ID: 9665369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis.
    Ackermann D; Vogt B; Escher G; Dick B; Reichen J; Frey BM; Frey FJ
    Hepatology; 1999 Sep; 30(3):623-9. PubMed ID: 10462366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of hepatic and renal 11 beta-hydroxysteroid dehydrogenase in rats with liver cirrhosis.
    Escher G; Nawrocki A; Staub T; Vishwanath BS; Frey BM; Reichen J; Frey FJ
    Gastroenterology; 1998 Jan; 114(1):175-84. PubMed ID: 9428231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between decrease of 11beta-hydroxysteroid dehydrogenase activity and hypokalemia induced by furosemide in rats.
    Yao B; Zhang YD; Shen JP
    Acta Pharmacol Sin; 2001 Nov; 22(11):991-6. PubMed ID: 11749789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man.
    Palermo M; Armanini D; Shackleton CH; Sorba G; Cossu M; Roitman E; Scaroni C; Delitala G
    Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):272-6. PubMed ID: 12373630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
    Ricketts ML; Stewart PM
    Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dietary potassium chloride intake augments rat renal mineralocorticoid receptor selectivity via 11beta-hydroxysteroid dehydrogenase.
    Hermans JJ; Fischer MA; Schiffers PM; Struijker-Boudier HA
    Biochim Biophys Acta; 1999 Nov; 1472(3):537-49. PubMed ID: 10564768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia causes down-regulation of 11 beta-hydroxysteroid dehydrogenase type 2 by induction of Egr-1.
    Heiniger CD; Kostadinova RM; Rochat MK; Serra A; Ferrari P; Dick B; Frey BM; Frey FJ
    FASEB J; 2003 May; 17(8):917-9. PubMed ID: 12626438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced 11beta-hydroxysteroid dehydrogenase activity in experimental nephrotic syndrome.
    Vogt B; Dick B; Marti HP; Frey FJ; Frey BM
    Nephrol Dial Transplant; 2002 May; 17(5):753-8. PubMed ID: 11981059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone metabolism in the human kidney and inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites.
    Quinkler M; Johanssen S; Grossmann C; Bähr V; Müller M; Oelkers W; Diederich S
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4165-71. PubMed ID: 10566667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inhibition of renal 11beta-hydroxysteroid dehydrogenase in the rat stimulates collecting duct sodium reabsorption.
    Bailey MA; Unwin RJ; Shirley DG
    Clin Sci (Lond); 2001 Aug; 101(2):195-8. PubMed ID: 11473496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats.
    Nowicki S; Opezzo JA; Levin G; Gonzalez D; Elias MM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1348-54. PubMed ID: 7562507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
    Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
    J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal tubular electrolyte transport during inhibition of renal 11beta-hydroxysteroid dehydrogenase.
    Biller KJ; Unwin RJ; Shirley DG
    Am J Physiol Renal Physiol; 2001 Jan; 280(1):F172-9. PubMed ID: 11133527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Succinate dehydrogenase and Na+-K+-ATPase activities in cells of rat kidney tubules during increased excretion of sodium, caused by furosemide].
    Krestinskaya TV; Manusova NB
    Vopr Med Khim; 1975; 21(4):375-9. PubMed ID: 129953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
    Vogt B; Dick B; N'Gankam V; Frey FJ; Frey BM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):811-4. PubMed ID: 10022459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.